Axsome Therapeutics (AXSM) Stock: Buy, Sell, or Hold?
$141.69
-2.68 (-1.86%)
âŧ
5d:
+7.04%
30d:
-12.42%
90d:
-34.48%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 02, 2026
0d
Protect AXSM Gains
Updated Nov 13, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (72%)
Quality Score
45/100
Position
FAIR
30-Day Fair Range
$138.48 â $165.45
Position: FAIR
Forward P/E & Valuation
41.9x
CHEAP
vs 68.1x historical avg
Wall Street Target
$265.86
+87.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$123.00 / $151.31
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: AXSM is fairly priced but lacks strong directional signals. At -15.0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Get Alerted When AXSM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$118.43
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$73.54
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AXSM is currently trading at $141.69, which is considered fair relative to its 30-day fair value range of $138.48 to $165.45. From a valuation perspective, the stock is trading at a discount (Forward PE: 41.9) compared to its historical average (68.1). Remarkably, the market is currently pricing in an annual earnings decline of 15.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, AXSM is in a strong downtrend. Immediate support is located at $123.00, while resistance sits at $151.31.
Market Sentiment: The stock scores a mixed 46/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $265.86 (+87.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AXSM is in a strong downtrend. Immediate support is located at $123.00, while resistance sits at $151.31.
Market Sentiment: The stock scores a mixed 46/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $265.86 (+87.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$138.48 -
$165.45
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
Trading Range & Key Levels
30-Day Trading Range
$138.48 -
$165.45
Current vs Trading Range
FAIR
Support Level
$123.00
Resistance Level
$151.31
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Protect Your Profits
Holding AXSM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (46/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 87.6% below Wall St target ($265.86)
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
41.91
Wall Street Target
$265.86
(+87.6%)
Revenue Growth (YoY)
51.9%
Profit Margin
-18.2%
Valuation Discount vs History
-15.0% cheaper
PE vs Historical
41.9 vs 68.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-15.0%
(market-implied from PE analysis)
1-Year Target
$127.52
(-10%)
2-Year Target
$114.77
(-19%)
3-Year Target
$103.29
(-27%)
3-Yr Target (if PE normalizes)
(PE: 42â68)
$167.84
(+19%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 41.9 to 68.1
Stabilization Target:
$230.24
(+62.5%)
PE Expansion Potential:
+62.5%
Share AXSM Analysis
Share this live AXSM analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (AXSM)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 13, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits users expressing bullish sentiment towards $AXSM, disregarding recent management comments and investor call information.
Key Retail Themes:
Disregard of recent management comments
Bullish sentiment towards $AXSM
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:20 PM ET
Data refreshes hourly during market hours. Next update: 6:20 PM
Data refreshes hourly during market hours. Next update: 6:20 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AXSM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 52 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 49 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 31 SELL |
|
ARWR
Arrowhead PharmaceuticalâĻ |
STRONG BUY
15 analysts |
$108 | 50 HOLD |
|
ZYME
Zymeworks Inc. Common StâĻ |
STRONG BUY
14 analysts |
$42 | 44 HOLD |
Advanced AXSM Option Strategies
Professional options setups generated by AI based on today's AXSM price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive AXSM Research Pages
